Heron Therapeutics logo
Heron Therapeutics HRTX
$ 1.25 2.93%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Heron Therapeutics EV/EBITDA Ratio 2011-2024 | HRTX

Annual EV/EBITDA Ratio Heron Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-4.31 -6.62 -8.08 -10.7 -5.8 -3.04 -6.46 -1.88 -2.22 -5.93 -1.45

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.45 -10.7 -5.13